SELLAS Life Sciences (SLS) Tax Rate (2013 - 2017)
SELLAS Life Sciences' (SLS) quarterly Tax Rate came in at 0.85% in Q4 2017, up 37.05% on a QoQ basis from 1.35% in Q3 2017.
SELLAS Life Sciences (SLS) Tax Rate (2013 - 2017) Analysis & Trends
SELLAS Life Sciences (SLS) has 2 years of Tax Rate data on file, last reported at 0.85% in Q4 2017.
- On a quarterly basis, Tax Rate changed N/A year-over-year to 0.85% in Q4 2017; TTM through Dec 2017 was 1.06%, a N/A change from a year earlier, with the FY2021 full-year figure at 1.13%, up 103.0% from the prior year.
- Tax Rate for Q4 2017 stood at 0.85%, up from 1.35% in the prior quarter.
- Over the last five years, Tax Rate for SLS reached as high as 22.91% in Q1 2013 and fell as low as 19.13% in Q2 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -0.34 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 5.61 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 12.29 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 17.68 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 12.51 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -13.70 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | SELLAS Life Sciences | 1.96 Bn | 1.96 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -0.85 |
| Dec 31, 2017 | -0.85 |
| Dec 31, 2017 | -0.85 |
| Sep 30, 2017 | -1.35 |
| Sep 30, 2017 | -1.35 |
| Sep 30, 2017 | -1.35 |
| Jun 30, 2017 | -2.31 |
| Jun 30, 2017 | -2.31 |
| Jun 30, 2017 | -2.31 |
| Dec 31, 2013 | -2.65 |
| Dec 31, 2013 | -2.65 |
| Dec 31, 2013 | -2.65 |
| Sep 30, 2013 | -14.26 |
| Sep 30, 2013 | -14.26 |
| Sep 30, 2013 | -14.26 |
| Jun 30, 2013 | -19.13 |
| Jun 30, 2013 | -19.13 |
| Jun 30, 2013 | -19.13 |
| Mar 31, 2013 | 22.91 |
| Mar 31, 2013 | 22.91 |